Compare Recursion Pharmaceuticals Inc (RXRX) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Toronto-Dominion Bank — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while Toronto-Dominion Bank trades at $120.5 (market cap $197.03B). The key difference: Toronto-Dominion Bank is far larger — about 128.8× Recursion Pharmaceuticals Inc's market cap, and Toronto-Dominion Bank pays a 2.62% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | TD | |
|---|---|---|
Market Cap | $1.53B | $197.03B |
Sector | Health | Financials |
52-Week High | $6.79 | $124.80 |
52-Week Low | $2.84 | $72.55 |
Enterprise Value | $946.50M | — |
Dividend Yield | — | 2.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
